Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
The global market for induced pluripotent stem cells (iPSCs) reached $2.1 billion in 2016. The market should reach $3.6 billion in 2021, increasing at a compound ... 11.6% from 2016 through 2021. The U.S. market for iPSCs reached over $1.0 billion in 2016. The market should reach $1.8 billion in 2021, increasing ...
“Biosame” entry, uninterrupted supply and companies’ strong front-end footprint requirement makes it distinctAfter a decade, JP Biosimilar guideline’s first revision expected in FY2020 –Demonstrate Ch...
... Asia-Pacific biotechnology industry had total revenues of $92.8bn in 2017, representing a compound annual growth rate (CAGR) of 6% between 2013 and 2017. The medical/healthcare ...
... biotechnology industry had total revenues of $67.9bn in 2017, representing a compound annual growth rate (CAGR) of 5.7% between 2013 and 2017. The medical/healthcare ... and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts REASONS TO BUY What was ...
... healthcare segment was the industry's most lucrative in 2017, with total revenues of $4.7bn, equivalent to 49.7% of the industry's overall value. Germany’s biotechnology ... and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts REASONS TO BUY What was ...
... /healthcare segment was the industry's most lucrative in 2017, with total revenues of $4.0bn, equivalent to 41.7% of the industry's overall value. In Italy, ... presentations and pitches by understanding the future growth prospects of the Italy biotechnology market with five year forecasts REASONS TO BUY What was ...
... to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts REASONS TO BUY What was ... the size of the Japan biotechnology market by value in 2017? What will be the size of the Japan biotechnology market in 2022? What factors are ...
... industry is mainly driven by biotechnology related to healthcare, segments that are boosted ... United Kingdom biotechnology market by value in 2017? What will be the size of the United Kingdom biotechnology market in 2022? What factors are affecting the strength of competition in the United Kingdom biotechnology ...
... between 2013 and 2017. The medical/healthcare segment was the industry's most lucrative in ... United States biotechnology market by value in 2017? What will be the size of the United States biotechnology market in 2022? What factors are affecting the strength of competition in the United States biotechnology ...
... the development, manufacturing, and marketing of products based on advanced biotechnology research. The global biotechnology industry had total revenues of $380.2bn in 2017, representing ... (CAGR) of 9.6% between 2013 and 2017. The medical/healthcare segment was the industry's most lucrative in 2017, with total ...
... /healthcare segment was the industry's most lucrative in 2017, with total revenues of $4.3bn, equivalent to 33% of the industry's overall value. Brazil’s ... presentations and pitches by understanding the future growth prospects of the Brazil biotechnology market with five year forecasts REASONS TO BUY What was ...
Key Questions Answered in the Report:What is the total addressable market (TAM) and the potential market opportunity for the global digital biomarkers market?What are the major market drivers and chal...
India bio-medical waste management market is expected to reach $ 39 million by 2024. With growing population in the country, the number of patients is also increasing, thereby resulting in high volume...
The global personalized retail nutrition & wellness market size is expected to reach USD 50.0 billion by 2025, according to a ... revenue. This is primarily due to well-established food and biotechnology industries in U.S., coupled with presence of several personalized nutrition companies in the country Habit Food ...
Hormones, Prostaglandins, Thromboxanes and Leukotrienes
Somatotropin, Its Derivs and Structural Analogues
Argentina Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Armenia Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Australia Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Austria Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Azerbaijan Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Belarus Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Belgium Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Bosnia and Herzegovina Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Bulgaria Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Canada Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Chile Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
China Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Croatia Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Czech Republic Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Denmark Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Estonia Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Finland Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
France Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Georgia Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Germany Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Greece Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Hungary Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
India Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Ireland Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Israel Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Italy Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Japan Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Kazakhstan Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Kyrgyzstan Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Latvia Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Lithuania Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Mexico Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Netherlands Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
Nigeria Trade of Hormones, Prostaglandins, Thromboxanes and Leukotrienes: Import, Export, Market Prospects
